Research Study

A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205
Principal Investigator 
Ging-Yuek Robin Hsiung

Overview

Body Locations and Systems 
Alzheimer's Disease
ClinicalTrials.gov# 
NCT04241068
Status 
Recruiting
Study Start/End 
Nov 30, 2020 to Oct 31, 2023
Locations 
UBC Hospital
Name/Title 
Mannie Fan, Research Coordinator
Phone 
604-822-0550
Email Address 
mannie.fan@vch.ca
Purpose of Study 

The purpose of the study is to evaluate the long-term safety and tolerability of aducanumab  in participants who had previously participated in aducanumab studies.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.